Previous 10 | Next 10 |
2024-04-18 08:06:51 ET DENVER, Colo., Apr 18, 2024 ( 247marketnews.com )- Benitec Biopharma Inc. (NASDAQ: BNTC ) reported positive interim clinical data and a private investment from the sale of 5,749,152 shares of its common stock at a price per share of $4.80 and 2,584,239 pre-fun...
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements across multiple measures of swallowing function in the first Phase 1b/2a clinical study subje...
2024-04-18 07:14:34 ET More on Benitec Netflix, Johnson & Johnson, Procter & Gamble And Baidu On Watch Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Read the full article on Seeking Alpha For further detai...
HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...
2024-04-14 07:51:01 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Breakfast: The Week Ahead
2024-04-13 10:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...
2024-04-12 15:00:09 ET More on the markets SPY: The Correction May Be Massive S&P 500: International Risk Assessment My Current View Of The Market: April 2024 Edition (Technical Analysis) Small business optimism hits 11-year low as stock bulls keep runnin...
HAYWARD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...
2024-02-23 16:18:31 ET More on Benitec Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Financial information for Benitec Read the full article on Seeking Alpha For further details see: Benitec Biopharma files fo...
2024-02-13 09:11:23 ET More on Benitec Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Financial information for Benitec Read the full article on Seeking Alpha For further details see: Benitec GAAP EPS of -$2.64
News, Short Squeeze, Breakout and More Instantly...
Benitec Biopharma Limited Company Name:
BNTC Stock Symbol:
NASDAQ Market:
Benitec Biopharma Limited Website:
2024-07-16 20:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-The post-dose average values for Total Pharyngeal Residue (i.e., the amount of solid food or liquid material remaining in the pharynx after the first swallow) remained meaningfully reduced at the 180-day post-dose assessment following the administration of the low dose of gene therapy BB-301 as ...
HAYWARD, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace ...